ODT
RhumbLine Advisers’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-17,002
| Closed | -$58K | – | 3175 |
|
|
2021
Q1 | $58K | Buy |
17,002
+664
| +4% | +$2.27K | ﹤0.01% | 2971 |
|
|
2020
Q4 | $314K | Buy |
16,338
+1,892
| +13% | +$36.4K | ﹤0.01% | 2643 |
|
|
2020
Q3 | $194K | Sell |
14,446
-1,538
| -10% | -$20.7K | ﹤0.01% | 2700 |
|
|
2020
Q2 | $677K | Buy |
15,984
+3,975
| +33% | +$168K | ﹤0.01% | 2210 |
|
|
2020
Q1 | $332K | Sell |
12,009
-400
| -3% | -$11.1K | ﹤0.01% | 2351 |
|
|
2019
Q4 | $403K | Buy |
12,409
+44
| +0.4% | +$1.43K | ﹤0.01% | 2466 |
|
|
2019
Q3 | $322K | Buy |
12,365
+2,854
| +30% | +$74.3K | ﹤0.01% | 2545 |
|
|
2019
Q2 | $349K | Buy |
+9,511
| New | +$349K | ﹤0.01% | 2538 |
|